On evolutionary origin of cancer
- PMID: 15743536
- PMCID: PMC555547
- DOI: 10.1186/1475-2867-5-5
On evolutionary origin of cancer
Abstract
BACKGROUND: The necessary and sufficient capabilities of cancer cell have been identified. Strikingly, this list does not include one that would seem to be a key property, namely the ability of cancer cells to kill their "host". This is believed to be a self-evident consequence of the other capabilities (e.g., metastasis), although the available evidence suggests a distinct killer function. Taking into account this unlisted property can significantly affect the current paradigm of carcinogenesis. PRESENTATION OF THE HYPOTHESIS: On the assumption that killer function is a key capability of the cancer cell, it is suggested that cancer has evolved as a mechanism of negative selection of mutant alleles of vitally important genes present in population. Similarly to apoptosis, which is an altruistic suicidal act of a damaged cell, cancer is an altruistic suicidal act of an individual who carries dangerous alleles and presents a hazard for genetic stability of the population. From this point of view, apoptosis is not a protection means against cancer as generally believed, but rather they are the first and second lines of defense against genome instability, respectively. TESTING THE HYPOTHESIS: The modern DNA array technology is capable of revealing gene expression profiles responsible for killer function of cancer cell as well as those specific targets in the body that are most strongly affected by the tumor growth. IMPLICATIONS OF THE HYPOTHESIS: This hypothesis suggests new avenues of cancer research as well as principally new therapeutic strategies.
Figures


Similar articles
-
Cancer: evolutionary, genetic and epigenetic aspects.Clin Epigenetics. 2010 Dec;1(3-4):85-100. doi: 10.1007/s13148-010-0010-6. Epub 2010 Sep 14. Clin Epigenetics. 2010. PMID: 22704202 Free PMC article.
-
Cancer: shift of the paradigm.Med Hypotheses. 2008 Dec;71(6):839-50. doi: 10.1016/j.mehy.2008.07.041. Epub 2008 Aug 31. Med Hypotheses. 2008. PMID: 18762386 Review.
-
Cancer as a programmed death of an organism.Biochemistry (Mosc). 2005 Sep;70(9):1055-64. doi: 10.1007/s10541-005-0224-y. Biochemistry (Mosc). 2005. PMID: 16266279
-
Mitochondrial biogenesis: pharmacological approaches.Curr Pharm Des. 2014;20(35):5507-9. doi: 10.2174/138161282035140911142118. Curr Pharm Des. 2014. PMID: 24606795
-
[Prevention of cancer and the dose-effect relationship: the carcinogenic effects of ionizing radiations].Cancer Radiother. 2009 Jul;13(4):238-58. doi: 10.1016/j.canrad.2009.03.003. Epub 2009 Jun 17. Cancer Radiother. 2009. PMID: 19539515 Review. French.
Cited by
-
Cancer: evolutionary, genetic and epigenetic aspects.Clin Epigenetics. 2010 Dec;1(3-4):85-100. doi: 10.1007/s13148-010-0010-6. Epub 2010 Sep 14. Clin Epigenetics. 2010. PMID: 22704202 Free PMC article.
-
Strategies of the War on Cancer: To Kill or to Neutralize?Front Oncol. 2019 Jan 10;8:667. doi: 10.3389/fonc.2018.00667. eCollection 2018. Front Oncol. 2019. PMID: 30687641 Free PMC article. No abstract available.
-
The real war on cancer: the evolutionary dynamics of cancer suppression.Evol Appl. 2013 Jan;6(1):11-9. doi: 10.1111/eva.12018. Epub 2012 Oct 10. Evol Appl. 2013. PMID: 23396311 Free PMC article.
-
Mechanisms and insights into drug resistance in cancer.Front Pharmacol. 2013 Mar 14;4:28. doi: 10.3389/fphar.2013.00028. eCollection 2013. Front Pharmacol. 2013. PMID: 23504227 Free PMC article.
-
Cell transformation and the evolution of a field of precancerization as it relates to oral leukoplakia.Int J Dent. 2011;2011:321750. doi: 10.1155/2011/321750. Epub 2011 Oct 5. Int J Dent. 2011. PMID: 22007217 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Research Materials